Validation study on the assay method for anti-factor IIa potency of enoxaparin sodium
2024

Testing Method for Enoxaparin Sodium Potency

Sample size: 3 publication 10 minutes Evidence: high

Author Information

Author(s): Yang Xiaorong, Zou Hanyan, Dong Yixue, Liu Bing, Wang Ying, Wang Mengying

Primary Institution: Chongqing Institute for Food and Drug Control

Hypothesis

Can a new assay method for anti-factor IIa potency of enoxaparin sodium improve reproducibility and reliability across laboratories?

Conclusion

The new assay method for enoxaparin sodium shows excellent specificity, linearity, robustness, precision, and accuracy, making it a reliable alternative to existing methods.

Supporting Evidence

  • The new method demonstrated high consistency and reproducibility with an RSD value of less than 2.0%.
  • Recovery rates for the test sample solutions ranged between 98.0% and 102.0%.
  • The method can be performed by a single operator using a multi-channel pipette, reducing the need for specialized equipment.
  • Validation results indicate that the method meets the guidelines of the Chinese Pharmacopoeia.
  • Results showed good consistency between two independent laboratories.

Takeaway

This study created a new way to test a blood thinner called enoxaparin that is easier and more reliable, helping doctors make sure it's safe for patients.

Methodology

The study integrated various testing methods to establish a validated assay for measuring anti-factor IIa potency using standard samples.

Potential Biases

Strict control of experimental conditions might be challenging to replicate in practical applications.

Limitations

The small sample size for inter-laboratory comparison may limit the statistical power of the results.

Digital Object Identifier (DOI)

10.7717/peerj.18732

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication